AtriCure Non Operating Income Net Other Over Time
| ATRC Stock | USD 32.65 0.85 2.67% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out AtriCure Performance and AtriCure Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.63) | Revenue Per Share | Quarterly Revenue Growth 0.158 | Return On Assets | Return On Equity |
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Non Operating Income Net Other Analysis
Compare AtriCure and related stocks such as Quidel, BioLife Solutions, and Kestra Medical Techn Non Operating Income Net Other Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QDEL | (173 K) | (173 K) | 11 K | 46 K | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (15.5 M) | (20 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.7 M) | (5.1 M) | (5.4 M) |
| BLFS | (76 K) | (76 K) | 16.1 K | (56.6 K) | 12.2 K | 21.8 K | (3.1 M) | (1.3 M) | (391 K) | (3 M) | 5 M | 5 M | 5 M | 5 M | 5 M | 5.7 M | 6 M |
| AZTA | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 19.4 M | 17.4 M | 15.5 M |
| TXG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 M | 1.3 M | (596 K) | 6.4 M | 6.4 M | 6.4 M | 7.4 M | 7.8 M |
| XERS | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (3.7 M) | (7.7 M) | (7.7 M) | (7.7 M) | (7.7 M) | (7.7 M) | (6.9 M) | (7.3 M) |
| SEM | (27.8 M) | (27.8 M) | 1.6 M | (16.3 M) | 16.8 M | 16.8 M | 51 M | (19.7 M) | (14.2 M) | (6.6 M) | 41.8 M | 46.6 M | 26.4 M | 26.4 M | 26.4 M | 30.4 M | 31.9 M |
| LMAT | 62 K | 62 K | (246 K) | (178 K) | (15 K) | (89 K) | (80 K) | 24 K | 237 K | 496 K | (122 K) | 81 K | 661 K | 661 K | 661 K | 760.1 K | 798.2 K |
AtriCure and related stocks such as Quidel, BioLife Solutions, and Kestra Medical Techn Non Operating Income Net Other description
My Equities
My Current Equities and Potential Positions
| AtriCure | ATRC |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 7555 Innovation Way, |
| Exchange | NASDAQ Exchange |
USD 32.65
Check out AtriCure Performance and AtriCure Correlation. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
AtriCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.